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Clincial cases of malaria infection during pregnancy
may result in placental1-5 and/or congenital malaria in-
fections.  Emerging evidence has also shown that
pregnant women could remain asymptomatic with ma-
laria parasitaemia6.  Hence, this study was designed to
assess the possible impact of asymptomatic maternal
peripheral malaria parasitaemia and Plasmodium fal-
ciparum specific-IgG during pregnancy on placental
and cord circulations.
Twenty-one pregnant women were recruited for this
study and blood was collected from maternal periph-
eral, placental and cord circulations after delivery for
serological screening of P. falciparum histidine rich
protein (hrp-2), detection of malaria parasites and
malaria specific antibody. Informed consent was ob-
tained from the subjects and the study design received
ethical approval.
The detection of P. falciparum hrp-2 antigen in blood
samples from peripheral, placental and cord circula-
tion of the pregnant women was carried out using pre-
coated monoclonal anti-P. falciparum hrp-2 wells
(Cellabs Pty, Australia).  The procedure was followed
as described by the manufacturer.  In brief, blood
sampels collected from the pregnant women stored in
ethylene-diamine-tetra acetic acid (EDTA) tubes were
frozen and thawed before analysis.  Thawed whole
blood samples 100 ?l reference positive and negative
controls (Cellabs Pty, Australia) were added to the
appropriately labelled pre-coated wells and incubated
at room temperature for 60 min.  This allows the fixing
of hrp-2 antigen in the blood or reference positive
control to the anti-hrp-2 coated wells.  The wells
were washed with 0.01 M phosphate buffered saline
(PBS)-tween solution thrice.  Then 100 ?l of (1 : 200)
diluted conjugate of enzyme labelled anti-human glob-
ulin was added to all the wells and incubated for 60
min at room temperature.  After washing as described
above, 50 ?l of (1 : 20) diluted 3,3’, 5,5’-tetramethyl-
benzidine (TMB) substrate chromogen was added to
the wells and placed in the dark room for 15 min for
colour development. The 50 ?l of HCl (2.5 M) was
added to stop the reaction and the colour developed
was read using a Dynatech MR 250 microplate read-
er at 450 nm.  The absorbance of this test is not pro-ONYENEKWE et al :  MALARIA IN PREGNANT WOMEN 73
portional to the level of parasitaemia.  The cut-off
point for samples positive for P. falciparum hrp-2 an-
tigen was determined as mean absorbance (+3 stan-
dard deviation) reference negative control.
The P. falciparum specific-IgG concentration in sam-
ples of the pregnant women was performed using pre-
coated P. falciparum antigen wells (Cellabs Pty, Aus-
tralia).  The procedure followed as described by the
manufacturer.  In brief, 100 ?l of diluted (1 : 100)
pregnant women sera, reference positive and negative
sera were added to appropriately labelled P. falci-
parum antigen coated wells and incubated in a humid
chamber for 60 min at 37 oC.  The washing, addition
of conjugate antibody and substrate chromogen and
stopping of the reaction and reading of absorbance of
colours developed and determination of cut-off point
was as described for P. falciparum hrp-2 antigen.
However, the absorbance of this test is proportional
to the concentration of the P. falciparum specific-IgG
in the samples.
The malaria parasite density was reported as number
of parasites per  microlitre of blood as previously de-
scribed by Rooth7.  Statistical anaylsis was performed
on data using ANOVA, student t-test, likelihood ratio
and p-value < 0.05 was considered significant.
The result showed that 15 (71%) of the maternal
peripheral, 18 (86%) of the placental and 9 (43%) of
the cord samples were sero-reactive to anti-P. falci-
parum hrp-2 antigen; while 6 (29%), 3 (24%) and 12
(57%) of the maternal peripheral, placental and cord
samples were non-reactive  with anti-P. falciparum
hrp-2 antigen respectively.  There was no strong likeli-
hood that maternal peripheral malaria parasitaemia in
asymptomatic pregnant women will result in parasi-
taemia of the cord circulation (likelihood ratio: 0.704,
p >0.1), or placental circulation (likelihood ratio:
0.038, p > 0.1).  However, there was a strong likeli-
hood that malaria parasitaemia of the placental circu-
lation will result in malaria parasitaemia of the cord
circulation (likelihood ratio: 4.357, p<0.05) (Table 1).
The mean (+ 2 SD) malaria parasites density ex-
pressed as number of parasites per microlitre of blood
was not significantly different amongst the different
circulations (p>0.l) (Table 2). However, the mean
(+ 2 SD) P. falciparum specific-IgG concentration
was significantly different amongst the malaria parasi-
taemia maternal peripheral, placental and cord circula-
tions (p<0.01) (Table 2).
Table 1. The likelihood ratio for malaria parasitaemia
between the maternal peripheral, placental and
cord circulations (n = 21)
Circulations Likelihood ratio p-value
Maternal peripheral vs. cord 0.704 0.1 ns
Placental vs. cord 4.357 < 0.05
Maternal peripheral vs. placental 0.038 0.1 ns
n—Number of subjects; ns—Not significant.
Table 2.  P. falciparum specific-IgG and malaria parasites density in maternal peripheral, placental and
cord circulations with malaria parasitaemia
Circulations Maternal Placental Cord ANOVA
peripheral
Pf-IgG 0.547 + 0.133 0.605 + 0.102 0.422 + 0.198 < 0.01
(n =15) (n =18) (n = 9)
MPD 483 + 274 356 + 230 386 + 273 > 0.1
(n =15) (n =18) (n = 9)
n — Number of subjects; MPD — Malaria parasite density.J  VECT  BORNE  DIS  41, SEPTEMBER & DECEMBER  2004 74
The finding of the present study shows high incidence
of malaria parasitaemia in various circulations in as-
ymptomatic individuals during pregnancy. This finding
is consistent with our earlier report of high prevalence
of asymptomatic malaria parasitaemia amongst preg-
nant women6.
Similarly, the present study observed that malaria
parasitaemia in the peripheral circulation of asymp-
tomatic pregnant women might not necessarily result in
placental and or congenital malaria parasitaemia in all
instances. However, in most instances, malaria
parasitaemia of the placental circulation resulted in
congenital malaria parasitaemia of the neonates. Thus,
over-reliance on maternal peripheral circulation for di-
agnosing and excluding possible congenital malaria in-
fections may conspicuously encourage high rates of
congenital malaria infection of the neonates because
clearance of the malaria parasites from the maternal
peripheral circulation does not exclude congenital ma-
laria. Hence, placental malaria parasitaemia should be
prevented in pregnant women due to the risk associ-
ated with congenital malaria infection.
However, the most effective way of controlling or
avoiding placental malaria parasitaemia is by prevent-
ing exposure of pregnant women to infective bites of
mosquitoes or by administration of effective antimalar-
ia drugs which helps to limit and/or clear the parasi-
taemia in pregnant women. It may not be easy to
identify such asymptomatic pregnant women with ma-
laria parasitaemia except by compulsory routine ante-
natal malaria screening. This is because such patients
rarely present with signs and symptoms of malaria8.
The lack of clinical evidence based on signs and
symptoms, excludes these subjects from early drug in-
tervention and thus exposes them to possible risk of
congenital malaria infection of the neonates.
It has been reported that malaria in pregnancy espe-
cially during the last trimester may result in alteration
of placental functionl,2 and could adversely affect the
feto-placental unit irrespective of the parity3,9-11.
Hence, extent of damage to the placental integrity
might be a strong indicator that determines the fre-
quency of parasites transmission to cord circulations in
an asymptomatic state as is likely in the present study.
The P. falciparum specific-IgG concentration was
significantly different amongst the different malaria
parasitaemia circulations. The concentration was least
in malaria parasitaemia cord circulations. However, in-
fection of cord circulations with malaria parasites
seemed to result in blood reduction in P. falciparum
specific-IgG concentration. This was clearly reflected
in this finding in which the concentration of the specific
antibody was significantly higher in un-infected cord
circulations compared with infected circulations, both
circulations having similar history of maternal peripheral
malaria parasitaemia. This will imply possible earlier ex-
haustion of protective specific antibody during neona-
tal life by neonates with congenital malaria infections.
In conclusion, this study showed that malaria
parasitaemia of the placental calculations has strong
likelihood to result in congenital malaria infection.
Therefore, over-reliance on maternal peripheral circu-
lation for high-risk congenital malaria infection should
be avoided.
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